Ecopol

Ecopol

Ecopol was established to manage the wealth generated by the Tabanella family's ownership of Ecoplast Group, a Milan-area manufacturer of industrial films and flexible packaging materials. The underlying fortune originates from Giorgio Tabanella's leadership of Ecoplast, a company he built into a publicly traded entity on the Italian stock exchange before its delisting. The office maintains a deliberately low public profile, with no dedicated website or promotional presence. The family office deploys capital primarily into European industrial and life-sciences companies, often taking significant minority stakes. Asset-class exposure spans direct public equities, private placements, and venture-stage biotech. Confirmed positions include a long-held stake in Deinove, the French renewable-chemicals company, which Ecopol supported across multiple funding rounds between 2015 and Deinove's eventual restructuring. The office also held a disclosed position in Italian plastics compounder Sirmax following its recapitalization, though the current holding status is not publicly confirmed. Geographic focus centers on Italy and France, with opportunistic exposure across the European Union. Ecopol operates with a lean team drawn from the Tabanella family and long-tenured advisors, without publishing headcount or organizational charts. The office is not known to manage external capital or operate as a multi-family platform. Adjacent vehicles include the family's residual ties to Ecoplast's industrial operations, though the manufacturing entity and the family office are legally distinct. In 2020, the Tabanella family consolidated control of Ecoplast through a voluntary tender offer, delisting the company from the Milan stock exchange — a move that underscored the family's preference for private, long-horizon control over quarterly reporting obligations. The firm's structural differentiator is its embedded industrial expertise: Tabanella invests in sectors he operated in for decades, making Ecopol one of the few European family offices that can serve as a genuine strategic co-investor in specialty-materials and bioplastics deals. This operator-informed mandate — deploying manufacturing-derived wealth back into manufacturing-adjacent innovation — creates natural deal flow from industry networks rather than GP-led fundraisings.